Stockreport

Investors in UroGen Pharma (NASDAQ:URGN) have unfortunately lost 42% over the last five years [Yahoo! Finance]

UroGen Pharma Ltd. - Ordinary Shares  (URGN) 
Last urogen pharma ltd. - ordinary shares earnings: 3/2 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.urogen.com
PDF UroGen Pharma Ltd. NASDAQ:URGN ), since the last five years saw the share price fall 42%. Furthermore, it's down 19% in about a quarter. That's not much fun for holders [Read more]